Keyphrases
Endothelial Dysfunction
100%
Randomized Double-blind Crossover Study
100%
Nebivolol
100%
Essential Hypertension
100%
Atenolol
62%
Acetylcholine
25%
Endothelium-dependent
25%
Endothelium-independent
25%
Forearm Blood Flow
25%
Sodium Nitroprusside
25%
Nitric Oxide Release
25%
L-NMMA
25%
Forearm
12%
Special Characters
12%
Hypertension
12%
Low Blood Pressure
12%
Treatment Duration
12%
Beta-blockers
12%
Endothelial Function
12%
Venous Occlusion Plethysmography
12%
Nitric Oxide
12%
Independent Pathway
12%
Arginine
12%
Hypertensive Patients
12%
Antihypertensive Drugs
12%
Endothelial Nitric Oxide
12%
Vascular Protection
12%
Placebo Run-in
12%
Bioactivity
12%
Intra-arterial Infusion
12%
Blood Pressure Control
12%
Ambulatory Blood Pressure
12%
Patients with Hypertension
12%
Vasodilator Responses
12%
Clinic Blood Pressure
12%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Dysfunction
100%
Essential Hypertension
100%
Bendroflumethiazide
100%
Nebivolol
100%
Atenolol
62%
Nitric Oxide
37%
Nitroprusside Sodium
25%
Acetylcholine
25%
N(g) Methylarginine
25%
Polyacrylamide Gel Electrophoresis
12%
Antihypertensive Agent
12%
Atherosclerosis
12%
Placebo
12%
Vein Occlusion
12%
Arginine
12%
Hypotension
12%
Neuroscience
Crossover Study
100%
Nebivolol
100%
Bendroflumethiazide
100%
Atenolol
62%
Nitric Oxide
37%
Acetylcholine
25%
N(g) Methylarginine
25%
Sodium Nitroprusside
25%
Polyacrylamide Gel Electrophoresis
12%
Placebo
12%
Arginine
12%
Antihypertensive Agent
12%